Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation

v3.8.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation

9. Stock-Based Compensation

 

A summary of the Company’s outstanding stock option activity for the years ended December 31, 2017 and 2016 is as follows:

 

          December 31, 2017        
          Weighted-
Average
    Weighted-
Average
Remaining
Contractual Life
       
    Options     Exercise Price     (Years)     Intrinsic Value  
Outstanding at December 31, 2016     11,446     $ 367.08       8.2     $      -  
Granted     -       -       -       -  
Exercised     -       -                   -       -  
Forfeited     -       -       -       -  
Expired     (144 )   $ 8,719.64       -       -  
Outstanding at December 31, 2017     11,302     $ 264.26       7.3     $ -  
Exercisable at December 31, 2017     9,835     $ 287.31       8.3     $ -  
Vested and expected to vest at December 31, 2017     11,302     $ 264.26       7.3     $                  -  

 

          December 31, 2016        
          Weighted-
Average
    Weighted-
Average
Remaining
Contractual Life
       
    Options     Exercise Price     (Years)     Intrinsic Value  
Outstanding at December 31, 2015     9,364     $ 498.60       -     $ -  
Granted     3,280       16.44                     -                                -  
Exercised     -            -       -       -  
Forfeited     -       -       -       -  
Expired     (1,198 )   $ 495.96       -       -  
Outstanding at December 31, 2016     11,446     $ 367.08       8.2     $ -  
Exercisable at December 31, 2016     8,996     $ 507.72       7.9     $ -  
Vested and expected to vest at December 31, 2016     11,446     $ 367.08       8.7     $ -  

 

The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of a peer group of similar companies. The expected term was calculated utilizing the simplified method. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The following weighted average assumptions were used in the calculation to estimate the fair value of options granted to employees during the year ended December 31, 2016, (no options were granted for the year ended December 31, 2017):

 

    December 31, 2016  
Weighted-average risk-free interest rate     1.63 %
Weighted-average expected life (in years)     6.30  
Expected dividend yield     0 %
Weighted-average expected volatility     66.00 %

 

Summary of Stock-Based Compensation Expense

 

Total stock-based compensation expense included in the consolidated statements of operations is allocated as follows (in thousands):

 

    As of December 31,  
    2017     2016  
Cost of revenue   $ 10     $ 17  
Research and development     64       104  
General and administrative     92       132  
Selling and marketing     53       17  
Capitalized into inventory     -       3  
    $ 219     $ 273  

 

Unrecognized stock-based compensation at December 31, 2016 and 2017 were as follows (in thousands):

 

    As of December 31, 2016  
          Weighted  
          Average  
          Remaining  
    Unrecognized
Stock-Based
    Period
of Recognition
 
    Compensation     (in years)  
Stock options   $                    256                    1.13  
                 

 

    As of December 31, 2017  
          Weighted  
          Average  
          Remaining  
    Unrecognized
Stock-Based
    Period
of Recognition
 
    Compensation     (in years)  
Stock options   $                   37                    0.40